News

The US has built three reactors in the past 30 years, but now Westinghouse will stand up 10 in partnership with Google. But ...
I have attached to this ticket a WIT file that describes a generic interface for graph database operations. This interface can be implemented by various providers, either by emulating features not ...
Vertex had plans to hire 1,300 employees in Wilmington, but it never even got close.
Vertex-frequency analysis (VFA) is a useful technique in graph signal processing to extract the correspondence between frequencies and vertices. VFA can be calculated by the windowed graph Fourier ...
Vertex's pipeline is poised to produce other big winners. I don't just think Vertex is a stock to buy on the dip -- I think it's a screaming buy.
Vertex Pharmaceuticals reported disappointing Q1 revenue and earnings. The company also revealed it is temporarily pausing part of a phase 1/2 study of experimental cystic fibrosis drug VX-522 ...
Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to trigger sufficient levels of insulin production in a phase 1/2 trial.
Vertex Pharmaceuticals (Nasdaq: VRTX) specialises in treatments for rare diseases. It has eight approved medicines on the market. Seven of these are medicines for various types of cystic fibrosis ...
As Vertex Pharmaceuticals reels from a painful trial readout for its pain candidate suzetrigine, the Boston biotech has chalked up a win in its specialty area of cystic fibrosis. | The FDA has ...
Vertex Pharmaceuticals offers a buying opportunity with strong Q3 earnings, robust pipeline, and healthy financials supporting growth potential.